Hydrodissection / Aspiration Cannula, 25 g. Angled Right

Micro instruments designed to provide maximum grasping, resecting capability, and excellent maneuverability for easy access to tight, small joints (wrist, elbow, and ankle).,Features pinless hinge d

Micro instruments designed to provide maximum grasping, resecting capability, and excellent maneuverability for easy access to tight, small joints (wrist, elbow, and ankle).,Features pinless hinge d

Made exclusively from LactoSorb Resorbable Copolymer.

The Stryker Cross-Screw System offers the surgeon a simple and secure method for ACL reconstruction utilizing soft tissue grafts. The Stryker Cross-Screw System provides the latest technology in femo

(Date:5/16/2008)... sufferers gain benefit from calcitriol, an oral f...-- Taking activated vitamin D may cut the risk of ...idney disease by about one quarter, a new study su... 1,400 patients, those being treated with calcitri... overall risk of death lowered by 26 percent when ...

(Date:5/16/2008)...vices for Frail Seniors and People With,Disabiliti...e/ -- Thousands of,homecare workers across the sta...oposed cuts to hours of service, wages and benefit...nerable workers and the,people they serve deeper i...ices for seniors and people with disabilities from...

(Date:5/16/2008)...ment for National HIV Vaccine Awareness Day, May,1...Twenty-six years into the,AIDS epidemic, someone i...U.S. On Sunday, May 18, HIV Vaccine Awareness Day,... National Institute of Allergy and Infectious,Dise...ive, urges everyone,to help end the AIDS epidemic ...

(Date:5/16/2008)...ire/ -- Huntsworth plc (LSE: HNT), "the Group",a ...are communications,group headquartered in London, ...t to the Group,s performance in the first quarter ...tatement follows below., 15 May 2008, ... Interim Management Statement, Re...

...ew investigational drug used in combination with a...fighting drug-resistant HIV, according to a Lancet...HIV/AIDS issue. The multinational phase III clini... and more than 30 centers in the United States, is...

...S sufferers and transplant patients are at a much ...ing a range of cancers, Australian research releas...he Lancet medical journal, suggests a link between...ferent types of cancer and could be a breakthrough...

...ian doctors continue to bear the brunt of police i...ators trying to unravel the hands behind the foile...tern Australia and also quizzed five doctors of fo...dian. However, WA Premier Alan Carpenter said he ...

...blem drinkers who took a craving-curbing drug when... heavy drinking days each month than drinkers who...eported marked reductions in heavy drinking days. ...of 403 heavy drinkers in Finland, who took either ...

(Date:5/15/2008)...reflects depth and breadth of, collaboration with... for diverse forms of cance...a(R), the leading IV, bisphosphonate, on relapse r... Four oral sessions to feature RAD001, first oral ...g first results of RECORD-1 study in renal cell ...

(Date:5/15/2008)...-FirstCall/ -- Sanofi-aventis,(EURONEXT: SAN and N...andmark ATHENA study showed Multaq(R) (dronedarone...ts with atrial fibrillation or atrial flutter,dec... or death from any,cause by a statistically signif...y endpoint. The ATHENA results will be presented a...

(Date:5/15/2008)...swire/ -- Ergonex Pharma today,announced that the ...as,granted orphan drug designation to Terguride fo... (PAH). Terguride is currently being evaluated for... FDA,s grant of orphan drug designation to Terguri...ent program by offering regulatory,clinical devel...

(Date:5/15/2008)...rstCall/ -- Novavax, Inc. (Nasdaq:,NVAX) today ann...se I/IIa,study of its pandemic influenza vaccine i...vorable interim results from the first phase of th...thy adult volunteers, were,reported in December 20...e,is well tolerated and immunogenic at the 15 micr...

...-FirstCall/ --,Advanced Magnetics today announced ...nical trials of ferumoxytol as an,intravenous (IV)...nted today at approximately 6:00 pm EDT as posters...al Meeting in Orlando,Florida. These posters are ... web site at <a target="_blank" href=,"http://www....

.../PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals,...t data at the Annual Meeting,of the American Assoc... 14-18, 2007 in Los Angeles, California. , Data be...n-clinical data on SNS-032, a highly selective and...s) 2, 7 and 9 that is,currently in a Phase 1 clini...